b'SMALL IDEA, BIG IMPACT:GLOBAL CHALLENGE AWARDWhen faced with a challenge like responding to a global pandemic, there are strong incentivesto accelerate innovation and put new technology to the test.In response to Covid-19, weve seen many examples of innovation, including technology powered by artificial intelligence (AI) to help track the outbreak, clean hospitals, deliver supplies and develop vaccines. Weve seenhow big data platforms can be mobilised quickly and transparently and be a force for good.AyeAI ConsultingAyeAM Autonomous AmbulanceAyeAI autonomous ambulance is self-contained and equipped with medical telepresence robot, Telemedicine Modalities Autonomous Vehicle Platform, that allow a remote physician to treat patientsas if in their clinic. The design is in line with guidelines for constructing ambulances, for land vehicles,and the Al is tuned for autonomous driving and navigation in off-road conditions.Darwin College, University of CambridgeJade: An AI-enabled low-cost digital stethoscopeJade is the first at-home stethoscope of its kind that provides a world-beating solution at a low cost.It is a completely open-source telehealth product for public welfare and is a totally affordable yet radical new approach that combines AIoT and medical technology to catapult the traditional stethoscope intoa revolutionized phase of usage. Oreoluwa GriffithsChewing Gum for Covid-19 testingThe main idea for this test is based on the idea that the virus can be detected in sufficient quantities for diagnosis in patients saliva. Since Covid-19 has been shown to exist on plastic surfaces for up to 80 hours (plastic being the main component of chewing gum), utilising simple chewing gum for the collection of sufficient amounts of saliva for viable testing is a suitable solution. Through the use of chewing gum, rapid, remote and early sample collection could be achieved.OxVentUniversity of Oxford, Kings College London, Smith & NephewThe OxVent, rapid design & manufacture low cost Ventilator for Covid-19The OxVent is a rapid manufacture low cost volume controlled ventilator for Covid-19. The aim was to design, test and distribute an easy to manufacture ventilator solution in order to rapidly upscale critical care infrastructure to meet the projected patient requirement for the pandemic. The aim was also to utilise components not required of industry standard systems, so as to relieve the logistical pressureon existing manufacturing efforts.VentilatorChallengeUK ConsortiumProducing ventilators for the NHSThe consortiums sole objective was to build ventilators swiftly and safely to meet the national need. VCUK progressed two ventilators (Smiths ParaPAC plus and the Penlon ESO 2) and worked collaboratively to establish new production sites and seven new sub-assembly sites around thecountry which were designed and operational within three weeks.Versarien PLC Graphene-based technology for large scale manufacture of antiviral (PPE) materialsand surfacesResponding to the global pandemic, our subsidiaries, 2-DTech Ltd. and Cambridge Graphene Ltd., developed a graphene-based technology that can be easily incorporated into textiles and other polymer materials providing them with enhanced antiviral properties. These graphene-enhanced textiles/polymers were used to develop antiviral facemasks and medical garments with enhanced performance, durability and comfortability.eandt.theiet.org/innovation#eandtawards 15'